MTOR/HDAC6-IN-1

This potent dual inhibitor targets HDAC6 and mTOR with IC50 values of 56 nM and 133.7 nM, respectively. It induces autophagy and apoptosis while inhibiting cell migration, showing research potential for triple-negative breast cancer (TNBC) in both cellular and animal models.